The risk of CNS recurrence was also higher in patients with high IPI and TP53 mutation, but the latter difference did not reach statistical significance ( supplemental Figure 3 D-E).
← all excerpts
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.
1
—
—